Why the study?
To evaluate the perfusion index at the 10th minute of admission and determine whether it can differentiate between NSTEMI and USAP patients in the emergency department at an early stage.
Does perfusion index at admission differentiate NSTEMI from unstable angina and predict 30-day mortality in patients with acute coronary syndrome?
Does perfusion index at admission differentiate NSTEMI from unstable angina and predict 30-day mortality in patients with acute coronary syndrome?
Perfusion index measured at admission may serve as an early, non-invasive marker to differentiate NSTEMI from unstable angina and predict short-term mortality.
PI at 10 min may aid early NSTEMI vs USAP differentiation and mortality prediction; leaves open diagnostic adoption pending larger prospective studies.
Background: We aimed to evaluate the perfusion index (PI) level at the 10th minute of admission to the emergency department in patients with non-ST-segment elevation myocardial infarction (NSTEMI) and unstable angina pectoris (USAP). In addition, we aimed to evaluate whether PI is useful in differentiating NSTEMI and USAP patients in the emergency department in the early stage.Materials and Methods: Eighty NSTEMI (Group 1) and 50 USAP (Group 2) patients who were consecutively admitted to our emergency department between November 2017 and May 2019 and diagnosed with acute coronary syndrome were included in the study. In both patient groups, PI measured with the Massimo-SET Root 7362A RDS7 non-invasive pulse oximetry probe and other routine laboratory measurements were measured and compared.Results: The mean PI was significantly lower in NSTEMI patients (p <0.001). At 30-day patient follow-up, the PI of the reduce was significantly lower (P <0.001). The area under the curve was significantly lower for PI in NSTEMI patients (area under the curve 0.313, p = 0.016). At 30-day patient follow-up, the level of PI was significantly lower in the died patients than the survived patients (P <0.001). The area under the curve was significantly lower for PI in NSTEMI patients (area under the curve 0.313, p = 0.016).Conclusions: Although our study shows that PI may be an early marker in the distinguish of NSTEMI and USAP patients and may be useful in predicting the mortality of these patients, more extensive studies will support our hypothesis.
No takes yet. Share an insight, caveat, or question.
Kaçmaz et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: